ABSTRACT Human cell lines of hematopoietic origin were tested for production of tumor necrosis factor (TNF) hTNF activity was not found in supernatants of cell lines of T-cell, monocytic, or promyelocytic origin. Partially purified hTNF has a molecular weight of approximately 70,000, has no interferon activity, is acid labile, is destroyed by heating at 70°C for 1 hr, induces cross-resistance to mouse TNF in vitro, and causes hemorrhagic necrosis of Meth A mouse sarcoma in the standard in vivo mouse TNF assay. Tests with a panel of 23 human cancer cell lines showed that hTNF is cytotoxic for 7 cell lines, cytostatic for 5, and has no effect on 11. Comparative studies with human a, fi, and y interferons indicated that sensitivity to hTNF and interferon can be distinguished. Combined treatment with hTNF and a or y interferon resulted in a synergistic cytotoxic effect.
but not for L cells resistant to mouse TNF. Exposure to 4fi-phorbol 123-myristate 13ci-acetate augmented production of hTNF.
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Tumor necrosis factor (TNF) was recognized by Carswell et al.
(1) during a study of the antitumor activity of serum from mice infected with bacillus Calmette-Guerin (BCG) and subsequently injected with endotoxin. Serum from these mice contains a factor that induces hemorrhagic necrosis of certain mouse sarcomas in vivo and has cytotoxic/cytostatic effects on mouse and human tumor cells in vitro (1) (2) (3) (4) (5) . Serum from mice singly treated with BCG or endotoxin did not have these properties. Other agents, such as Corynebacterium parvum or zymosan, that cause hyperplasia of the reticuloendothelial system and increase sensitivity to endotoxin lethality, can substitute for BCG in priming for TNF release. Endotoxin, however, appears to be unique in its ability to elicit TNF release (1, (4) (5) (6) . By using these methods for TNF production, factors with TNF-like activities have also been found in rats (1) and rabbits (1, 7, 8) .
Biochemical characterization has shown that mouse serum TNF exists in at least two forms: a 150,000 Mr form (4, 9) and a 40,000-60,000 Mr form (3) (4) (5) . TNF in rabbit serum has been reported to have a molecular weight of 39,000 (10) and 67,000 (11) . Our studies have indicated that both in vivo and in vitro activities of mouse TNF appear to be a property of the same molecule. The cellular source of TNF in the mouse was initially assumed to be the macrophage, because the agents used to prime for TNF production cause massive hyperplasia of macrophages in liver and spleen (1) . From studies of macrophage-rich cell populations in vitro, Matthews (12) and Mannel et al. (13) reached a similar conclusion with regard to the source of mouse and rabbit TNF. Direct evidence that macrophages are at least one cell type in the mouse capable of producing TNF comes from studies with cloned lines of mouse histiocytomas (ref. 13 ; unpublished data). These cells constitutively produce low levels of TNF that are greatly increased after exposure to endotoxin.
In the present study we have examined the capacity of human cell lines of hematopoietic origin to produce a TNF-like factor.
MATERIALS AND METHODS
Cell Lines. See Tables 1 and 2 . LuKII cells were obtained from W. Stewart (14) . B-cell lines transformed by Epstein-Barr virus were derived from patients with melanoma (15) . These and other cell lines were from our cell bank or from the collection of J0rgen E. Fogh or Peter Ralph of Sloan-Kettering Institute.
In Vitro TNF Assay. TNF-sensitive and -resistant L-M cells were derived from clone 929 mouse L cells (American Type Culture Collection). TNF activity was assayed by adding equal volumes of serially diluted samples to wells (24-well Costar plates) seeded 2-3 hr previously with 5 x 104 trypsinized L cells and determining cell death at 48 hr by phase-contrast microscopy (1 Table 1 were screened for TNF production by using the L cell assay system developed for the detection of mouse TNF (1, 6 Table 1 shows that cell lines of B-cell origin produce a factor with TNF-like activity-e.g., cytotoxic for L(s) but not L(Rr-and that PMA is necessary for efficient TNF production. No TNF activity was detected in the supernatants of six T-cell or three monocytic cell lines (with or without PMA stimulation). The LuKII line consistently produced high levels of TNF after PMA induction and was therefore selected as the source for subsequent studies of TNF production and characterization.
Fractionation and Characterization of Human TNF (hTNF). Concentrated samples of LuKII supernatants were fractionated on DEAE-Sephadex A-50 columns and individual fractions were assayed on bs) and L(R) cells. TNF activity was detected in the initial flow-through fractions, and peak fractions were pooled and concentrated. The specific activity of these preparations was 2-5 x 104 units/mg of protein (a 25-fold increase over the initial supernatants), and these preparations were used for characterization. The molecular weight of hTNF was estimated to be approximately 70,000. hTNF activity was destroyed by a 12-hr exposure to low or high pH: 90% of the activity was lost at fractions of culture medium alone. Limulus assays indicated no difference in the amount of endotoxin in TNF-active and TNFinactive (control) fractions.
Cytotoxic or Cytostatic Effect of hTNF on Human Tumor Cell Lines. Fig. 1 illustrates the effect of hTNF on four cell lines: BT-20 breast cancer line (cytotoxic effect), ME-180 cervical cancer line (cytotoxic effect), SK-MEL-109 melanoma line (cytostatic effect), and T-24 bladder cancer line (no effect). Table 2 summarizes the results of tests with 23 tumor cell lines and 4 cultures of normal cells. With a 35% or greater reduction in cell viability or cell number at 7 days as the criterion of either cytotoxicity or cytostasis, hTNF has a cytotoxic effect on 7 cell lines, a cytostatic effect on 5 cell lines, and no effect on 15 lines. Three of four cell lines of breast cancer origin were sensitive to the cytotoxic effect of hTNF, whereas the predominant effect of hTNF on melanoma cell lines was cytostasis. None of the four cultures derived from normal tissues was hTNF sensitive. Fig. 4 shows the influence of combined treatment with hTNF and recombinant IFNa or natural IFN-y. Synergistic effects of hTNF and IFN are clearly evident in tests with BT-20, ME-180, and SK-MEL-109, in which the combined cytotoxic effect is greater than that seen with hTNF or IFN alone. Similar results were obtained with mouse TNF and human IFNs a and y. By using the approach suggested by Clarke (17) , the combined cytotoxic effect of IFN and hTNF was clearly shown to be synergistic rather than additive. Neither mouse nor human partially purified TNF has de- CT, cytotoxic; CS, cytostatic. 
DISCUSSION

